Craig Collins struggled with his condition before committing to the long path through surgeries—and fitness—to muscle up.

Eli Lilly has received approval from the US FDA for Omvoh to treat moderately to severely active Crohn's disease in the adult ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

The drug is already approved in the US to treat ulcerative colitis, another form of inflammatory bowel disease ...

Crohn’s disease and ulcerative colitis (UC) are both types of inflammatory bowel disease (IBD) that share similar symptoms but differ in their affected areas, disease progression, and treatment ...

Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and ...

Crohn’s disease is a type of inflammatory bowel disease (IBD). It primarily affects the ileum, or the end section of your small intestine. It’s also commonly found in the first section of your ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...

17,000 people answered the IBD UK Patient Survey, and the results reveal patients are facing long waits at every stage of the ...

Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Omvoh ...